IDiyas

For the Inventor, By the Inventor

Tokyo, Japan

Satoshi Ohya

USPTO Granted Patents = 10

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:

goldMedal10 out of 613 
 
Sankyo Company, Limited
 patents

Years Active: 1994-2007

Loading Chart...
10 patents (USPTO):Explore Patents
1. 7157442 - Antibacterial compound (2007-01-02),
2. 6391903 - Triazole derivatives having antifungal activity (2002-05-21),
3. 6337403 - Triazole derivatives having antifungal activity (2002-01-08),
4. 6180621 - Method and treatment using 1-methylcarbapenem derivatives as an anti-helicobacter pylori agent (2001-01-30),
5. 6090802 - 1- Methylcarbapenem derivatives (2000-07-18),
6. 5977097 - 1-methylcarbapenem derivatives (1999-11-02),
7. 5866564 - Carbapenem derivatives, their preparation and their use as antibiotics (1999-02-02),
8. 5712267 - Carbapenem derivatives, their preparation and their use as antibiotics (1998-01-27),
9. 5420119 - Carbapenem derivatives having antibiotic activity, their preparation and (1995-05-30),
10. 5310735 - Carbapenem derivatives having antibiotic activity, their preparation and (1994-05-10),

Title: Satoshi Ohya: Innovator in Antibacterial and Antifungal Compounds

Introduction

Satoshi Ohya is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address bacterial and fungal infections. With a total of 10 patents to his name, Ohya's work has the potential to impact medical treatments significantly.

Latest Patents

One of Satoshi Ohya's latest patents involves an antibacterial compound. This invention relates to a compound of formula (I), where R and R represent various groups, including aryl, heterocyclic, alkyl, and alkenyl groups, which may be optionally substituted. The compound also includes a hydrogen atom or a hydroxyl group, with X and X representing oxygen, sulfur, or nitrogen atoms that may be substituted. This invention encompasses a pharmaceutical composition that utilizes the described compound as an active ingredient for preventing or treating bacterial infections. Furthermore, it outlines a method for administering a pharmacologically effective amount of the compound to warm-blooded animals for the prevention or treatment of such infections.

Another notable patent by Ohya focuses on triazole derivatives that exhibit antifungal activity. These innovations are crucial in the ongoing battle against resistant bacterial and fungal strains.

Career Highlights

Satoshi Ohya is currently associated with Sankyo Company, Limited, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments that can improve patient outcomes.

Collaborations

Ohya has collaborated with notable colleagues, including Isao Kawamoto and Yukio Utsui. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Satoshi Ohya's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his role as a key inventor in the fight against bacterial and fungal infections. His work continues to pave the way for new treatments that can benefit many patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…